Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Sanofi announced an expansion of its partnership with McLaren Racing. The two companies, alongside United Autosports, are ...

Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

After announcing successful trial results for its lead mRNA treatment earlier this year, Regulus Therapeutics agreed to be ...

Which tariffs will have the most impact on the Pharma industry? Jason Waite: Thus far, the recently announced tariffs have ...

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Market access is about aligning internal strategies with external realities that often change without warning and at a ...

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.